Novavax (NVAX) IV at 133 into developing Covid-19 vaccine
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) 30-day option implied volatility is at 133; compared to its 52-week range of 85 to 312 into developing Covid-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) call put ratio 1 call to 1.3 puts into quarter results
- Palo Alto Networks (PANW) call put ratio 1 call to 1.1 puts into quarter results
- Gold.com (GOLD) call put ratio 2.4 calls to 1 put into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
